InvestorsHub Logo
Followers 3
Posts 1176
Boards Moderated 0
Alias Born 03/02/2018

Re: None

Thursday, 02/28/2019 12:58:51 PM

Thursday, February 28, 2019 12:58:51 PM

Post# of 50157
I've asked for an opinion on this recently ... but never received any response.
My question comes to mind again today with the latest news release:

http://delcath.com/investors-news/

Why is it that we never recognize the already FDA-approved procedure known as "Chemoembolization" which has been being used for metastatic liver cancer (including ocular melanoma) for quite some time.
The treatment/procedure is also known as "TACE".
The specialists I've spoken to at Mayo Clinic and Piedmont are not highly impressed with PHP trials. Perhaps they know something that the typical Delcath enthusiast does not;
after all, it's they're job to "know".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News